Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects

Journal of Neuroinflammation

Volumn 11, Issue 1, 2014, Pages

  Noailles, Agustina ^a   Fernández Sánchez, Laura ^a   Lax, Pedro ^a   Cuenca, Nicolás ^a  

^a UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Confocal microscopy; Glia; Neuroprotection; Retinitis pigmentosa

Indexed keywords

CD11B ANTIBODY; IBA1 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 ANTIBODY; PROTEIN ANTIBODY; SODIUM CHLORIDE; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; TAUROCHENODEOXYCHOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; MICROGLIA; MICROGLIA ACTIVATION; NEUROPROTECTION; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; RETINA; RETINA GANGLION CELL; RETINAL PLEXIFORM LAYER; RETINITIS PIGMENTOSA; SPRAGUE DAWLEY RAT; SUBRETINAL SPACE; TREATMENT DURATION; ANIMAL; CELL COUNT; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY; RETINA DEGENERATION;

ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MICROGLIA; MICROSCOPY, CONFOCAL; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RETINAL DEGENERATION; TAUROCHENODEOXYCHOLIC ACID;

EID: 84938682250     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-014-0186-3     Document Type: Article

References (66)

1. Dryja TP, McGee TL, Hahn LB, Cowley GS, Olsson JE, Reichel E, Sandberg MA, Berson EL: Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med 1990, 323(19):1302-1307.
2. Dryja TP, McEvoy JA, McGee TL, Berson EL: Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2000, 41(10):3124-3127.
3. Kaushal S, Khorana HG: Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 1994, 33(20):6121-6128.
4. Illing ME, Rajan RS, Bence NF, Kopito RR: A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem 2002, 277(37):34150-34160.
5. Remé CE, Grimm C, Hafezi F, Marti A, Wenzel A: Apoptotic cell death in retinal degenerations. Prog Retin Eye Res 1998, 17(4):443-464.
6. Cuenca N, Fernández-Sánchez L, Campello L, Maneu V, De la Villa P, Lax P, Pinilla I: Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res 2014, 43C:17-75.
7. Dheen ST, Kaur C, Ling EA: Microglial activation and its implications in the brain diseases. Curr Med Chem 2007, 14(11):1189-1197.
8. Smith JA, Das A, Ray SK, Banik NL: Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 2012, 87(1):10-20.
9. Beynon SB, Walker FR: Microglial activation in the injured and healthy brain: what are we really talking about? Practical and theoretical issues associated with the measurement of changes in microglial morphology. Neuroscience 2012, 225:162-171.
10. Karlstetter M, Ebert S, Langmann T: Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology 2010, 215(9-10):685-691.
11. Zeng HY, Zhu XA, Zhang C, Yang LP, Wu LM, Tso MO: Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest Ophthalmol Vis Sci 2005, 46(8):2992-2999.
12. Hughes EH: Generation of activated sialoadhesin-positive microglia during retinal degeneration. Invest Ophthalmol Vis Sci 2003, 44(5):2229-2234.
13. Roque RS, Imperial CJ, Caldwell RB: Microglial cells invade the outer retina as photoreceptors degenerate in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 1996, 37:196-203.
14. Benveniste EN: Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992, 263(1 Pt 1):C1-C16.
15. Harry GJ: Microglia during development and aging. Pharmacol Ther 2013, 139(3):313-326.
16. Lucin KM, Wyss-Coray T: Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 2009, 64(1):110-122.
17. Polazzi E, Monti B: Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol 2010, 92(3):293-315.
18. Gupta N, Brown KE, Milam AH: Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 2003, 76(4):463-471.
19. Ardeljan D, Chan CC: Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res 2013, 37:68-89.
20. Penfold PL, Madigan MC, Gillies MC, Provis JM: Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001, 20(3):385-414.
21. Bosco A, Crish SD, Steele MR, Romero CO, Inman DM, Horner PJ, Calkins DJ, Vetter ML: Early reduction of microglia activation by irradiation in a model of chronic glaucoma. PLoS One 2012, 7(8):e43602.
22. Bosco A, Steele MR, Vetter ML: Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 2011, 519(4):599-620.
23. Gallego BI, Salazar JJ, de Hoz R, Rojas B, Ramírez AI, Salinas-Navarro M, Ortín-Martínez A, Valiente-Soriano FJ, Avilés-Trigueros M, Villegas-Perez MP, Vidal-Sanz M, Triviño A, Ramírez JM: IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J Neuroinflammation 2012, 9:92.
24. Abcouwer SF: Angiogenic factors and cytokines in diabetic retinopathy. J Clin Cell Immunol 2013, Suppl 1(11):1-12.
25. Gao JJ, Diesl V, Wittmann T, Morrison DC, Ryan JL, Vogel SN, Follettie MT: Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J Leukoc Biol 2002, 72(6):1234-1245.
26. Ling Z, Zhu Y, Tong CW, Snyder JA, Lipton JW, Carvey PM: Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp Neurol 2006, 199(2):499-512.
27. Hayashi Y, Tomimatsu Y, Suzuki H, Yamada J, Wu Z, Yao H, Kagamiishi Y, Tateishi N, Sawada M, Nakanishi H: The intra-arterial injection of microglia protects hippocampal CA1 neurons against global ischemia-induced functional deficits in rats. Neuroscience 2006, 142(1):87-96.
28. Imai F, Suzuki H, Oda J, Ninomiya T, Ono K, Sano H, Sawada M: Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab 2007, 27(3):488-500.
29. Lai AY, Todd KG: Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 2008, 56(3):259-270.
30. Langmann T: Microglia activation in retinal degeneration. J Leukoc Biol 2007, 81(6):1345-1351.
31. LaVail, M: Retinal degeneration Rat model resource. UCSF School of Medicine.
32. Fernández-Sánchez L, Lax P, Isiegas C, Ayuso E, Ruiz JM, de la Villa P, Bosch F, de la Rosa EJ, Cuenca N: Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa. Hum Gene Ther 2012, 23(12):1290-1300.
33. Fernández-Sánchez L, Lax P, Esquiva G, Martín-Nieto J, Pinilla I, Cuenca N: Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats. PLoS One 2012, 7(8):e43074.
34. Fernández-Sánchez L, Lax P, Pinilla I, Martín-Nieto J, Cuenca N: Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. Invest Ophthalmol Vis Sci 2011, 52(8):4998-5008.
35. Cuenca N, Kolb H: Circuitry and role of substance P-immunoreactive neurons in the primate retina. J Comp Neurol 1998, 393(4):439-456.
36. Cuenca N, De Juan J, Kolb H: Substance P-immunoreactive neurons in the human retina. J Comp Neurol 1995, 356(4):491-504.
37. Esteve-Rudd J, Campello L, Herrero MT, Cuenca N, Martín-Nieto J: Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system. Brain Res 2010, 1352:70-82.
38. Martínez-Navarrete GC, Martín-Nieto J, Esteve-Rudd J, Angulo A, Cuenca N: Alpha synuclein gene expression profile in the retina of vertebrates. Mol Vis 2007, 13:949-961.
39. Rasband, W: ImageJ Software National Institutes of Health, Bethesda, MD.
40. Cuenca N, Pinilla I, Sauvé Y, Lu B, Wang S, Lund RD: Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. Neuroscience 2004, 127(2):301-317.
41. Cuenca N, Pinilla I, Sauvé Y, Lund R: Early changes in synaptic connectivity following progressive photoreceptor degeneration in RCS rats. Eur J Neurosci 2005, 22(5):1057-1072.
42. Ashwell KW, Holländer H, Streit W, Stone J: The appearance and distribution of microglia in the developing retina of the rat. Vis Neurosci 1989, 2(5):437-448.
43. Zeng XX, Ng YK, Ling EA: Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 2000, 17(3):463-471.
44. Yang P, de Vos AF, Kijlstra A: Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide. Invest Ophthalmol Vis Sci 1996, 37(1):77-85.
45. Wässle H, Riemann HJ: The mosaic of nerve cells in the mammalian retina. Proc R Soc Lond B Biol Sci 1978, 200(1141):441-461.
46. Ahnelt PK, Kolb H: The mammalian photoreceptor mosaic-adaptive design. Prog Retin Eye Res 2000, 19(6):711-777.
47. Lam TT, Kwong JM, Tso MO: Early glial responses after acute elevated intraocular pressure in rats. Invest Ophthalmol Vis Sci 2003, 44(2):638-645.
48. Buschini E, Piras A, Nuzzi R, Vercelli A: Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol 2011, 95(1):14-25.
49. Ng TF, Streilein JW: Light-induced migration of retinal microglia into the subretinal space. Invest Ophthalmol Vis Sci 2001, 42(13):3301-3310.
50. Zhang C, Shen JK, Lam TT, Zeng HY, Chiang SK, Yang F, Tso MO: Activation of microglia and chemokines in light-induced retinal degeneration. Mol Vis 2005, 11:887-895.
51. Peng B, Xiao J, Wang K, So KF, Tipoe GL, Lin B: Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa. J Neurosci 2014, 34(24):8139-8150.
52. Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, Enaida H, Ishibashi T: Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 2013, 120(1):e5-e12.
53. Lax P, Esquiva G, Altavilla C, Cuenca N: Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration. Exp Eye Res 2014, 120:175-185.
54. Kanazawa H, Ohsawa K, Sasaki Y, Kohsaka S, Imai Y: Macrophage/microgliaspecific protein Iba1 enhances membrane ruffling and Rac activation via phospholipase C-gamma-dependent pathway. J Biol Chem 2002, 277(22):20026-20032.
55. Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S: Microglia-specific localization of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 1998, 57(1):1-9.
56. Ohsawa K, Imai Y, Sasaki Y, Kohsaka S: Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem 2004, 88(4):844-856.
57. Sasaki Y, Ohsawa K, Kanazawa H, Kohsaka S, Imai Y: Iba1 is an actin-cross-linking protein in macrophages/microglia. Biochem Biophys Res Commun 2001, 286(2):292-297.
58. Yanguas-Casás N, Barreda-Manso MA, Nieto-Sampedro M, Romero-Ramírez L: Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. J Neuroinflammation 2014, 11:50.
59. Gaspar JM, Martins A, Cruz R, Rodrigues CM, Ambrósio AF, Santiago AR: Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose. Neuroscience 2013, 253:380-388.
60. Park J, Choi H, Min JS, Park SJ, Kim JH, Park HJ, Kim B, Chae JI, Yim M, Lee DS: Mitochondrial dynamics modulate the expression of proinflammatory mediators in microglial cells. J Neurochem2013, 127(2):221-232.
61. Muzio L, Martino G, Furlan R: Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia. J Neuroimmunol 2007, 191(1-2):39-44.
62. Harada T, Harada C, Kohsaka S, Wada E, Yoshida K, Ohno S, Mamada H, Tanaka K, Parada LF, Wada K: Microglia-Müller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 2002, 22(21):9228-9236.
63. Roque RS, Rosales AA, Jingjing L, Agarwal N, Al-Ubaidi MR: Retina-derived microglial cells induce photoreceptor cell death in vitro. Brain Res 1999, 836(1-2):110-119.
64. Zhou WT, Ni YQ, Jin ZB, Zhang M, Wu JH, Zhu Y, Xu GZ, Gan DK: Electrical stimulation ameliorates light-induced photoreceptor degeneration in vitro via suppressing the proinflammatory effect of microglia and enhancing the neurotrophic potential of Müller cells. Exp Neurol 2012, 238(2):192-208.
65. Arroba AI, Alvarez-Lindo N, van Rooijen N, de la Rosa EJ: Microglia-mediated IGF-I neuroprotection in the rd10 mouse model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2011, 52(12):9124-9130.
66. Hanisch UK, Kettenmann H: Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10(11):1387-1394.